Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Steven Thorpe

Concepts (206)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma
21
2026
209
5.110
Why?
Soft Tissue Neoplasms
11
2024
133
3.530
Why?
Bone Neoplasms
16
2026
272
2.810
Why?
Margins of Excision
3
2024
55
1.710
Why?
Osteosarcoma
6
2026
100
1.110
Why?
Intraoperative Care
2
2024
68
1.030
Why?
Frozen Sections
1
2024
23
0.850
Why?
Surgical Oncology
1
2024
30
0.830
Why?
Sarcoma, Ewing
3
2025
103
0.510
Why?
Extremities
7
2023
142
0.510
Why?
Practice Patterns, Physicians'
1
2024
1408
0.440
Why?
Tomography, X-Ray Computed
3
2024
2786
0.420
Why?
Killer Cells, Natural
4
2026
481
0.390
Why?
Chondrosarcoma
2
2025
17
0.370
Why?
Subtalar Joint
1
2012
6
0.360
Why?
Flatfoot
1
2012
15
0.350
Why?
Sarcoma, Synovial
2
2023
20
0.350
Why?
Knee Joint
2
2026
453
0.340
Why?
Prognosis
14
2025
4351
0.330
Why?
Medical Oncology
2
2025
345
0.330
Why?
Subclavian Artery
1
2011
28
0.330
Why?
Deltoid Muscle
1
2010
6
0.320
Why?
Cellulitis
1
2011
55
0.320
Why?
Thoracic Vertebrae
1
2011
90
0.310
Why?
Compartment Syndromes
1
2010
36
0.310
Why?
Joint Instability
1
2012
187
0.300
Why?
Humans
48
2026
146342
0.280
Why?
Deglutition Disorders
1
2011
159
0.280
Why?
Osteomyelitis
1
2011
148
0.280
Why?
Health Status Disparities
2
2021
322
0.270
Why?
SEER Program
4
2021
233
0.270
Why?
Stair Climbing
1
2026
6
0.240
Why?
Retrospective Studies
14
2024
17438
0.240
Why?
Social Class
3
2023
260
0.230
Why?
Socioeconomic Factors
4
2023
1327
0.230
Why?
Neoplasms
4
2022
2954
0.230
Why?
Neoplasm Recurrence, Local
3
2021
1160
0.220
Why?
Receptors, Immunologic
1
2026
210
0.220
Why?
Young Adult
11
2026
14330
0.220
Why?
Knee
1
2025
81
0.210
Why?
Follow-Up Studies
9
2024
5439
0.210
Why?
Synovitis, Pigmented Villonodular
1
2024
3
0.200
Why?
Giant Cell Tumor of Tendon Sheath
1
2024
9
0.200
Why?
Middle Aged
18
2025
36619
0.200
Why?
Survival Rate
7
2024
2092
0.200
Why?
Subcutaneous Fat
1
2024
80
0.200
Why?
Cost-Benefit Analysis
2
2024
640
0.200
Why?
Thorax
1
2023
51
0.200
Why?
Intra-Abdominal Fat
1
2024
104
0.190
Why?
Femoral Neoplasms
1
2022
10
0.190
Why?
Muscle, Skeletal
2
2025
1818
0.180
Why?
Neoplasm Staging
2
2023
1488
0.180
Why?
Musculoskeletal Diseases
1
2023
95
0.180
Why?
Male
23
2026
73396
0.180
Why?
Adult
16
2026
41087
0.180
Why?
Bone Diseases
1
2022
60
0.180
Why?
Foot Diseases
1
2021
17
0.170
Why?
Arthrodesis
2
2012
38
0.170
Why?
Osteoarthritis
1
2024
206
0.170
Why?
Aged, 80 and over
6
2024
8391
0.160
Why?
Neoadjuvant Therapy
3
2021
475
0.160
Why?
Radiation Oncology
1
2021
83
0.160
Why?
Radiotherapy, Adjuvant
4
2023
222
0.160
Why?
Female
22
2026
79499
0.160
Why?
Walking
1
2025
546
0.160
Why?
Interleukin-15
1
2020
96
0.160
Why?
Body Composition
1
2024
689
0.160
Why?
Societies, Medical
1
2024
907
0.150
Why?
Hand
1
2021
157
0.150
Why?
Reoperation
2
2022
645
0.150
Why?
Arteries
1
2021
261
0.150
Why?
Spine
1
2021
184
0.150
Why?
Insurance, Health
1
2022
318
0.150
Why?
Lymphocytes, Tumor-Infiltrating
1
2020
156
0.150
Why?
Combined Modality Therapy
2
2025
1271
0.150
Why?
Hematologic Neoplasms
1
2021
170
0.140
Why?
Thoracic Wall
1
2019
22
0.140
Why?
Thoracic Neoplasms
1
2019
40
0.140
Why?
Aged
11
2024
26432
0.140
Why?
Radiography
2
2012
861
0.140
Why?
Health Equity
1
2021
139
0.140
Why?
Adolescent
11
2026
22557
0.140
Why?
Hemipelvectomy
1
2018
1
0.140
Why?
Healthcare Disparities
2
2023
733
0.140
Why?
Lower Extremity
1
2022
453
0.130
Why?
Vascular Surgical Procedures
1
2021
352
0.130
Why?
Free Tissue Flaps
1
2018
53
0.130
Why?
CD8-Positive T-Lymphocytes
1
2023
931
0.120
Why?
Postoperative Complications
3
2019
3034
0.120
Why?
Radiotherapy
1
2018
209
0.120
Why?
Osteotomy
2
2022
138
0.120
Why?
Child
10
2024
22693
0.120
Why?
Transcription Factors
1
2024
1730
0.120
Why?
Preoperative Care
1
2019
396
0.120
Why?
Lymphocytes
1
2018
379
0.120
Why?
C-Reactive Protein
1
2018
429
0.110
Why?
Databases, Factual
2
2021
1493
0.110
Why?
Health Care Costs
1
2019
423
0.110
Why?
Body Mass Index
1
2024
2458
0.110
Why?
Incidence
4
2021
2936
0.100
Why?
Age Factors
3
2021
3347
0.100
Why?
Tumor Microenvironment
3
2023
747
0.100
Why?
Range of Motion, Articular
2
2026
446
0.100
Why?
Infant, Newborn
5
2024
6460
0.090
Why?
United States
8
2022
16136
0.090
Why?
Treatment Outcome
6
2022
11821
0.090
Why?
Anti-Bacterial Agents
1
2023
1942
0.090
Why?
Biomechanical Phenomena
2
2026
874
0.090
Why?
Tarsal Bones
1
2012
14
0.090
Why?
Neutrophils
1
2018
1133
0.090
Why?
Torso
2
2023
36
0.090
Why?
Surveys and Questionnaires
1
2024
6073
0.090
Why?
California
2
2024
475
0.080
Why?
Osseointegration
1
2011
60
0.080
Why?
Debridement
1
2011
86
0.080
Why?
Infant
5
2024
10114
0.080
Why?
Immobilization
1
2010
54
0.080
Why?
Fatal Outcome
1
2011
302
0.080
Why?
Child, Preschool
5
2024
11913
0.070
Why?
Necrosis
1
2010
243
0.070
Why?
Pain Measurement
1
2012
573
0.070
Why?
Cervical Vertebrae
1
2011
170
0.070
Why?
Orthopedic Procedures
1
2012
260
0.070
Why?
Proportional Hazards Models
2
2023
1331
0.070
Why?
Prospective Studies
4
2024
8123
0.070
Why?
Spinal Fusion
1
2011
265
0.060
Why?
Recovery of Function
1
2012
725
0.060
Why?
Cell Line, Tumor
2
2026
3545
0.060
Why?
Carcinoma, Squamous Cell
1
2012
628
0.060
Why?
Head and Neck Neoplasms
1
2012
563
0.060
Why?
Risk Assessment
2
2018
3712
0.060
Why?
Rotation
1
2026
124
0.060
Why?
Cohort Studies
3
2021
6077
0.060
Why?
Isocitrate Dehydrogenase
1
2025
71
0.060
Why?
Sex Factors
2
2021
2107
0.060
Why?
Pelvis
1
2026
129
0.060
Why?
Pain
1
2011
790
0.060
Why?
Ankle Joint
1
2026
135
0.050
Why?
Disease-Free Survival
2
2020
778
0.050
Why?
Magnetic Resonance Imaging
2
2019
3926
0.050
Why?
Severity of Illness Index
1
2012
2921
0.050
Why?
Natural Cytotoxicity Triggering Receptor 1
1
2023
3
0.050
Why?
Smoking
1
2011
1486
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2024
250
0.050
Why?
Gait
1
2026
322
0.050
Why?
Watchful Waiting
1
2024
90
0.050
Why?
Mice
3
2026
18297
0.050
Why?
Electromyography
1
2025
428
0.050
Why?
Drug Evaluation, Preclinical
1
2023
195
0.050
Why?
Molecular Targeted Therapy
1
2025
447
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2012
1998
0.040
Why?
Antibiotic Prophylaxis
1
2023
140
0.040
Why?
Bone Marrow
1
2023
310
0.040
Why?
Prosthesis Failure
1
2022
126
0.040
Why?
Vascular Grafting
1
2021
14
0.040
Why?
Adaptor Proteins, Signal Transducing
1
2024
429
0.040
Why?
Sacrum
1
2022
80
0.040
Why?
Genetic Testing
1
2024
492
0.040
Why?
Xenograft Model Antitumor Assays
1
2024
930
0.040
Why?
Neuroectodermal Tumors, Primitive, Peripheral
1
2021
4
0.040
Why?
Vascular Patency
1
2021
115
0.040
Why?
Animals
4
2026
38106
0.040
Why?
Prosthesis Implantation
1
2022
156
0.040
Why?
Insurance Coverage
1
2022
248
0.040
Why?
Femur
1
2022
264
0.040
Why?
Bone and Bones
1
2023
319
0.040
Why?
Prosthesis Design
1
2022
358
0.040
Why?
Surgical Wound Infection
1
2023
349
0.040
Why?
Guideline Adherence
1
2024
594
0.040
Why?
Dogs
1
2020
517
0.040
Why?
Sarcopenia
1
2020
100
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2024
1432
0.030
Why?
Early Detection of Cancer
1
2023
506
0.030
Why?
Kaplan-Meier Estimate
1
2020
970
0.030
Why?
Leukocyte Count
1
2018
321
0.030
Why?
Organ Preservation
1
2018
123
0.030
Why?
Biocompatible Materials
1
2020
432
0.030
Why?
Inpatients
1
2021
540
0.030
Why?
Perfusion
1
2018
255
0.030
Why?
Tissue Engineering
1
2020
442
0.030
Why?
Practice Guidelines as Topic
1
2024
1591
0.030
Why?
Disease Models, Animal
1
2026
4580
0.030
Why?
Survival Analysis
1
2019
1378
0.030
Why?
Biopsy
1
2019
1075
0.030
Why?
Graft Survival
1
2018
523
0.030
Why?
Wound Healing
1
2018
354
0.030
Why?
Ischemia
1
2018
421
0.030
Why?
Mutation
1
2025
4093
0.030
Why?
Medicare
1
2019
920
0.020
Why?
Registries
1
2021
2400
0.020
Why?
Predictive Value of Tests
1
2018
2113
0.020
Why?
Signal Transduction
1
2025
5246
0.020
Why?
Carboplatin
1
2012
168
0.020
Why?
Radiotherapy Dosage
1
2012
289
0.020
Why?
Pseudarthrosis
1
2011
14
0.020
Why?
Radiotherapy, Intensity-Modulated
1
2012
143
0.020
Why?
Spinal Stenosis
1
2011
31
0.020
Why?
Paclitaxel
1
2012
260
0.020
Why?
Radiculopathy
1
2011
38
0.020
Why?
Chemoradiotherapy
1
2012
238
0.020
Why?
Bone Transplantation
1
2011
91
0.020
Why?
Hospitalization
1
2021
2475
0.020
Why?
Quality of Life
1
2021
3200
0.020
Why?
Risk Factors
1
2022
10921
0.020
Why?
Time Factors
1
2018
7109
0.020
Why?
Randomized Controlled Trials as Topic
1
2012
1763
0.010
Why?
Thorpe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)